Skip to main content
Displaying 13 - 24 of 68
Display:
12
24
48
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Unmet needs in PBC: the patient perspective
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome & objectives
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC
Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure
Webcasts
View
Viral Hepatitis
Discussion / Q&A
Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?
Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?
Webcasts
View
Cirrhosis & Complications
Summary and Conclusions “from a fluid to a medicine”
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy